Skip to Main Content

Author Details

Joost J C Verhoeff
University Medical Center Utrecht
2005
108
21
PMIDPaper TitleJournal TitlePublished Year
37652302A Framework for Assessing the Effect of Cardiac and Respiratory Motion for Stereotactic Arrhythmia Radioablation Using a Digital Phantom With a 17-Segment Model: A STOPSTORM.eu Consortium Study.Int J Radiat Oncol Biol Phys2024
36135366Occurrence, Risk Factors, and Consequences of Postoperative Ischemia After Glioma Resection: A Retrospective Study.Neurosurgery2023
37527331Accelerated respiratory-resolved 4D-MRI with separable spatio-temporal neural networks.Med Phys2023
37543057Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review.Radiother Oncol2023
37686575Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery-A Preliminary Analysis and Case Report.Cancers (Basel)2023
37541279Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.Lancet Oncol2023
37457228Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.Neurooncol Pract2023
37283211SynthRAD2023 Grand Challenge dataset: Generating synthetic CT for radiotherapy.Med Phys2023
37339638Real-time myocardial landmark tracking for MRI-guided cardiac radio-ablation using Gaussian Processes.Phys Med Biol2023
37033340Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma-a prospective multicenter observational study pointing out new unmet needs.Transl Cancer Res2023
37473612Exploring contrast generalisation in deep learning-based brain MRI-to-CT synthesis.Phys Med2023
37066114The impact of schizophrenia spectrum disorder, bipolar disorder and borderline personality disorder on radiotherapy treatment and overall survival in cancer patients: A matched pair analysis.Clin Transl Radiat Oncol2023
36996627CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.Eur J Cancer2023
36592740Dosimetric feasibility of direct post-operative MR-Linac-based stereotactic radiosurgery for resection cavities of brain metastases.Radiother Oncol2023
36879464STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe.Europace2023
36610310The impact of etiology in lesion-symptom mapping - A direct comparison between tumor and stroke.Neuroimage Clin2023
36843274Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.Int J Cancer2023
36927251Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancer.Acta Oncol2023
36210631On the feasibility of cardiac substructure sparing in magnetic resonance imaging guided stereotactic lung radiotherapy.Med Phys2023
34718916Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?Ann Surg Oncol2022
35608378Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach.Neurosurgery2022
35437259Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.Neurology2022
35855455Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients.Neurooncol Pract2022
35427556In Reply to Chow and Simone.Int J Radiat Oncol Biol Phys2022
35393451Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer.Sci Rep2022
35817325First experimental demonstration of VMAT combined with MLC tracking for single and multi fraction lung SBRT on an MR-linac.Radiother Oncol2022
36274570Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.Eur J Cancer2022
35963398Quantifying the post-radiation accelerated brain aging rate in glioma patients with deep learning.Radiother Oncol2022
36096039Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review.Eur J Cancer2022
35923896Towards mid-position based Stereotactic Body Radiation Therapy using online magnetic resonance imaging guidance for central lung tumours.Phys Imaging Radiat Oncol2022
35887688The Association between Muscle Quantity and Overall Survival Depends on Muscle Radiodensity: A Cohort Study in Non-Small-Cell Lung Cancer Patients.J Pers Med2022
36388422Screening for long-term complications in brain tumor care, thinking one step ahead.Neurooncol Pract2022
36191990Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors.Anticancer Res2022
35189610First experimental exploration of real-time cardiorespiratory motion management for future stereotactic arrhythmia radioablation treatments on the MR-linac.Phys Med Biol2022
35287380Feasibility of cardiac-synchronized quantitative T<sub>1</sub> and T<sub>2</sub> mapping on a hybrid 1.5 Tesla magnetic resonance imaging and linear accelerator system.Phys Imaging Radiat Oncol2022
35128399Irradiation of the subventricular zone and subgranular zone in high- and low-grade glioma patients: an atlas-based analysis on overall survival.Neurooncol Adv2022
35243030Clinical utility of convolutional neural networks for treatment planning in radiotherapy for spinal metastases.Phys Imaging Radiat Oncol2022
35243025The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis.Clin Transl Radiat Oncol2022
35083155Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.Front Oncol2022
34806396Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.Ann Palliat Med2022
34456061Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study.Curr Probl Cancer2022
32814843Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.Prostate Cancer Prostatic Dis2021
33827065Simultaneous multi-slice accelerated 4D-MRI for radiotherapy guidance.Phys Med Biol2021
33790766Sarcoma of the Heart Treated with Stereotactic MR-Guided Online Adaptive Radiation Therapy.Case Rep Oncol2021
33738451A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.Neurooncol Adv2021
33532631Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework.Clin Transl Radiat Oncol2021
33665386Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study.Clin Transl Radiat Oncol2021
33777759Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer.Front Oncol2021
33634347Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study.Clin Exp Metastasis2021
33631792The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis.Neuro Oncol2021
  • 1 - 50 of 108

Recommended Authors

University of California San Francisco
Career Start Year 2016
Number of shared co-authors 0
Stanford University
Career Start Year 2014
Number of shared co-authors 0
Medical University of Innsbruck
Career Start Year 2012
Number of shared co-authors 1
Juravinski Cancer Centre
Career Start Year 2011
Number of shared co-authors 0
Emory University
Career Start Year 2011
Number of shared co-authors 0
University of Toronto
Career Start Year 2010
Number of shared co-authors 2
Medical University of Innsbruck
Career Start Year 2010
Number of shared co-authors 1
Medical University of Vienna
Career Start Year 2009
Number of shared co-authors 1
Medical University of Innsbruck
Career Start Year 2009
Number of shared co-authors 0
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2002
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 0
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 2
University of California san francisco
Career Start Year 1998
Number of shared co-authors 2
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1997
Number of shared co-authors 2
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 0
University of Minnesota
Career Start Year 1994
Number of shared co-authors 0
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1992
Number of shared co-authors 1
Medical University of Vienna
Career Start Year 1991
Number of shared co-authors 2
Northwestern University
Career Start Year 1990
Number of shared co-authors 2
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Co-authored papers 11
Leiden University Medical Center, Haaglanden Medical Center
Co-authored papers 11
St Olavs University Hospital
Co-authored papers 6
Maastro Clinic
Co-authored papers 5
Oncode Institute
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 4
University Medical Center Utrecht
Co-authored papers 3
Cancer Center, University Medical Center Utrecht
Co-authored papers 3
Co-authored papers 2
Belgium International Drug Development Institute
Co-authored papers 2
Maastricht University Medical Center+
Co-authored papers 2
Eindhoven University of Technology
Co-authored papers 2
Oncode Institute
Co-authored papers 2
Maastricht University
Co-authored papers 2
University of Western Ontario
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Co-authored papers 1
German Cancer Research Center (DKFZ)
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
Sahlgrenska University Hospital
Co-authored papers 1
Santa Croce e Carle Hospital
Co-authored papers 1
The Institute of Cancer Research, UK Computational Biology Research Centre
Co-authored papers 1
Utrecht University
Co-authored papers 1
Champalimaud Clinical Center/Champalimaud Foundation
Co-authored papers 1
Institute for Advanced Study, University of Amsterdam.
Co-authored papers 1